Actos

Actos Recall

Actos has been linked to severe health complications such as bladder cancer, heart failure, liver failure, bone fractures, and eye problems. Still, the U.S. Food and Drug Administration (FDA) has yet to issue a full recall of the drug, though the agency has released a drug safety announcement that highlights the potential dangers of Actos. Drug regulators in Germany and France have ordered doctors there to stop prescribing Actos.

Before the FDA approved Actos in 1999, premarket studies had shown that test animals had developed bladder tumors. Actos manufacturer Takeda Pharmaceuticals launched a study to investigate long-term bladder cancer risks, and, after five years, the study showed an increased risk for bladder cancer. A study in France has demonstrated an increase in bladder cancer risk due to Actos as well.

Know Your Legal Rights

Even though there has not been an official FDA recall of Actos, patients who took the drug and suffered adverse effects may still have legal rights. Many former Actos users are filing lawsuits as a result of developing bladder cancer or heart problems after taking the drug. These lawsuits claim that the maker of the drug did not warn the FDA or the public about the risks associated with Actos.

If you or someone you know have suffered from bladder cancer or complications because of Actos, we are here to help. Simply fill out the form to learn more.